Literature DB >> 24167084

Fixation effect of SurePath preservative fluids using epidermal growth factor receptor mutation-specific antibodies for immunocytochemistry.

Akihiko Kawahara1, Tomoki Taira, Hideyuki Abe, Kosuke Watari, Yuichi Murakami, Chihiro Fukumitsu, Yorihiko Takase, Tomohiko Yamaguchi, Koichi Azuma, Jun Akiba, Mayumi Ono, Masayoshi Kage.   

Abstract

BACKGROUND: Cytological diagnosis of respiratory disease has become important, not only for histological typing using immunocytochemistry (ICC) but also for molecular DNA analysis of cytological material. The aim of this study was to investigate the fixation effect of SurePath preservative fluids.
METHODS: Human lung cancer PC9 and 11-18 cell lines, and lung adenocarcinoma cells in pleural effusion, were fixed in CytoRich Blue, CytoRich Red, 15% neutral-buffered formalin, and 95% ethanol, respectively. PC9 and 11-18 cell lines were examined by ICC with epidermal growth factor receptor (EGFR) mutation-specific antibodies, the EGFR mutation DNA assay, and fluorescence in situ hybridization. The effect of antigenic storage time was investigated in lung adenocarcinoma cells in pleural effusion by ICC using the lung cancer detection markers.
RESULTS: PC9 and 11-18 cell lines in formalin-based fixatives showed strong staining of EGFR mutation-specific antibodies and lung cancer detection markers by ICC as compared with ethanol-based fixatives. DNA preservation with CytoRich Blue and CytoRich Red was superior to that achieved with 95% ethanol and 15% neutral-buffered formalin fixatives, whereas EGFR mutations by DNA assay and EGFR gene amplification by fluorescence in situ hybridization were successfully identified in all fixative samples. Although cytoplasmic antigens maintained high expression levels, expression levels in nuclear antigens fell as storage time increased.
CONCLUSIONS: These results indicate that CytoRich Red is not only suitable for ICC with EGFR mutation-specific antibodies, but also for DNA analysis of cytological material, and is useful in molecular testing of lung cancer, for which various types of analyses will be needed in future.
© 2013 American Cancer Society.

Entities:  

Keywords:  cell block; epidermal growth factor receptor mutation-specific antibodies; immunocytochemistry; liquid-based cytology; lung cancer

Mesh:

Substances:

Year:  2013        PMID: 24167084     DOI: 10.1002/cncy.21355

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


  7 in total

1.  Quantitative Proteomic Analysis Identifies AHNAK (Neuroblast Differentiation-associated Protein AHNAK) as a Novel Candidate Biomarker for Bladder Urothelial Carcinoma Diagnosis by Liquid-based Cytology.

Authors:  Hyebin Lee; Kwangsoo Kim; Jongmin Woo; Joonho Park; Hyeyoon Kim; Kyung Eun Lee; Hyeyeon Kim; Youngsoo Kim; Kyung Chul Moon; Ji Young Kim; In Ae Park; Bo Bae Shim; Ji Hye Moon; Dohyun Han; Han Suk Ryu
Journal:  Mol Cell Proteomics       Date:  2018-06-27       Impact factor: 5.911

Review 2.  Immunocytochemistry for predictive biomarker testing in lung cancer cytology.

Authors:  Deepali Jain; Aruna Nambirajan; Alain Borczuk; Gang Chen; Yuko Minami; Andre L Moreira; Noriko Motoi; Mauro Papotti; Natasha Rekhtman; Prudence A Russell; Spasenija Savic Prince; Yasushi Yatabe; Lukas Bubendorf
Journal:  Cancer Cytopathol       Date:  2019-05-03       Impact factor: 5.284

3.  Method for preservation of DNA stability of liquid-based cytology specimens from a lung adenocarcinoma cell line.

Authors:  Yukiko Matsuo; Kazuya Yamashita; Tsutomu Yoshida; Yukitoshi Satoh
Journal:  Virchows Arch       Date:  2020-08-31       Impact factor: 4.064

4.  The effect of the small amount of formaldehyde in the SurePath liquid when establishing protocols for immunocytochemistry.

Authors:  Ellen Cathrine Bjønness-Jacobsen; Anne Kristine Kallevåg Eriksen; Vidar Nyløkken Hagen; Kirsten Margrethe Østbye; Anna Wittersø; Mette Kristin Pedersen; Torill Sauer
Journal:  Cytojournal       Date:  2016-11-16       Impact factor: 2.091

5.  Diagnostic algorithm for determining primary tumor sites using peritoneal fluid.

Authors:  Cheol Keun Park; Douglas P Malinowski; Nam Hoon Cho
Journal:  PLoS One       Date:  2018-07-19       Impact factor: 3.240

6.  Comprehensive validation of liquid-based cytology specimens for next-generation sequencing in cancer genome analysis.

Authors:  Toshiaki Akahane; Tomomi Yamaguchi; Yasutaka Kato; Seiya Yokoyama; Taiji Hamada; Yukari Nishida; Michiyo Higashi; Hiroshi Nishihara; Shinsuke Suzuki; Shinichi Ueno; Akihide Tanimoto
Journal:  PLoS One       Date:  2019-06-14       Impact factor: 3.240

7.  Evaluation of the VE1 Antibody in Thyroid Cytology Using Ex Vivo Papillary Thyroid Carcinoma Specimens.

Authors:  Yon Hee Kim; Hyunee Yim; Yong-Hee Lee; Jae Ho Han; Kyi Beom Lee; Jeonghun Lee; Euy Young Soh; Seon-Yong Jeong; Jang-Hee Kim
Journal:  J Pathol Transl Med       Date:  2015-12-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.